NASDAQ:EKSO Ekso Bionics (EKSO) Stock Price, News & Analysis $1.07 +0.04 (+3.88%) (As of 07/5/2024 08:52 PM ET) Add Compare Share Share Today's Range$1.02▼$1.0750-Day Range$1.00▼$1.4552-Week Range$0.62▼$3.13Volume34,000 shsAverage Volume135,702 shsMarket Capitalization$19.44 millionP/E RatioN/ADividend YieldN/APrice Target$6.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Ekso Bionics alerts: Email Address Ekso Bionics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside484.1% Upside$6.25 Price TargetShort InterestHealthy0.46% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.43) to ($0.19) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.56 out of 5 starsMedical Sector636th out of 879 stocksGeneral Industrial Machinery, Industry5th out of 7 stocks 3.5 Analyst's Opinion Consensus RatingEkso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEkso Bionics has only been the subject of 2 research reports in the past 90 days.Read more about Ekso Bionics' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.46% of the outstanding shares of Ekso Bionics have been sold short.Short Interest Ratio / Days to CoverEkso Bionics has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ekso Bionics has recently decreased by 28.43%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldEkso Bionics does not currently pay a dividend.Dividend GrowthEkso Bionics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EKSO. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Ekso Bionics this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Ekso Bionics to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ekso Bionics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.10% of the stock of Ekso Bionics is held by insiders.Percentage Held by InstitutionsOnly 6.42% of the stock of Ekso Bionics is held by institutions.Read more about Ekso Bionics' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Ekso Bionics are expected to grow in the coming year, from ($0.43) to ($0.19) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ekso Bionics is -1.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ekso Bionics is -1.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEkso Bionics has a P/B Ratio of 1.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Ekso Bionics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. About Ekso Bionics Stock (NASDAQ:EKSO)Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.Read More EKSO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EKSO Stock News HeadlinesJuly 7 at 3:16 AM | americanbankingnews.comEkso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.comJune 17, 2024 | globenewswire.comEkso Bionics Appoints Deborah Lafer Scher to its Board of DirectorsJuly 8, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.June 7, 2024 | globenewswire.comArtificial Intelligence in the Global Prosthetic Market 2024-2033, with Profiles of Ossur, Blatchford, Ottobock, Ekso Bionics, Open Bionics, Advanced Arm Dynamics and BrainRoboticsMay 12, 2024 | stockhouse.comEkso Indego Personal to be Featured on 'Health Uncensored' with Dr. Drew PinskyMay 10, 2024 | finance.yahoo.comEkso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew PinskyMay 10, 2024 | globenewswire.comEkso Indego Personal to be Featured on ‘Health Uncensored' with Dr. Drew PinskyMay 1, 2024 | finanznachrichten.deEkso Bionics Holdings, Inc.: Ekso Bionics Announces First Quarter 2024 Financial ResultsJuly 8, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.May 1, 2024 | finance.yahoo.comEkso Bionics Holdings First Quarter 2024 Earnings: Misses ExpectationsMay 1, 2024 | markets.businessinsider.comOptimistic Outlook for Ekso Bionics with Strong International Presence and CMS Reimbursement ApprovalApril 30, 2024 | washingtonpost.comHSBC: Q1 Earnings SnapshotApril 30, 2024 | finance.yahoo.comQ1 2024 Ekso Bionics Holdings Inc Earnings CallApril 30, 2024 | finance.yahoo.comEkso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Earnings Call TranscriptApril 30, 2024 | finance.yahoo.comEkso Bionics Holdings Inc (EKSO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...April 29, 2024 | investorplace.comEKSO Stock Earnings: Ekso Bionics Holdings Misses EPS, Misses Revenue for Q1 2024April 29, 2024 | sfgate.comEkso Bionics: Q1 Earnings SnapshotApril 29, 2024 | globenewswire.comEkso Bionics Announces First Quarter 2024 Financial ResultsSee More Headlines Receive EKSO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/29/2024Today7/07/2024Next Earnings (Estimated)7/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry General industrial machinery, Sub-IndustryN/A Current SymbolNASDAQ:EKSO Previous SymbolOTCMKTS:EKSOD CUSIPN/A CIK1549084 Webwww.eksobionics.com Phone(510) 984-1761Fax510-927-2647Employees70Year FoundedN/APrice Target and Rating Average Stock Price Target$6.25 High Stock Price Target$10.00 Low Stock Price Target$2.50 Potential Upside/Downside+484.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,200,000.00 Net Margins-79.48% Pretax Margin-79.48% Return on Equity-95.36% Return on Assets-46.29% Debt Debt-to-Equity Ratio0.33 Current Ratio2.81 Quick Ratio2.11 Sales & Book Value Annual Sales$18.28 million Price / Sales1.06 Cash FlowN/A Price / Cash FlowN/A Book Value$0.85 per share Price / Book1.26Miscellaneous Outstanding Shares18,170,000Free Float17,065,000Market Cap$19.44 million OptionableOptionable Beta1.51 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Scott G. Davis (Age 54)CEO & Director Comp: $535.8kMr. Jerome Wong (Age 50)Corporate Controller, Corporate Secretary & CFO Comp: $356.81kMr. Jason C. JonesChief Operating OfficerMs. Rachael AndersonGlobal Director of Marketing & Strategic GrowthMr. Anthony PrattVice President of SalesMs. Ann CooksonHuman Resources DirectorMs. Foon Lim ChweePresident of APACMr. Stephan AderholdSenior VP & GM of EMEAMore ExecutivesKey CompetitorsPalladyne AINASDAQ:PDYNA2Z Smart TechnologiesNASDAQ:AZNauticus RoboticsNASDAQ:KITTAltra Industrial MotionNASDAQ:AIMCSymboticNASDAQ:SYMView All CompetitorsInsiders & InstitutionsKent Lake Capital LLCBought 454,892 shares on 5/16/2024Ownership: 3.280%Scott G DavisSold 37,446 sharesTotal: $37,446.00 ($1.00/share)Jerome WongSold 12,784 sharesTotal: $12,784.00 ($1.00/share)View All Insider TransactionsView All Institutional Transactions EKSO Stock Analysis - Frequently Asked Questions How have EKSO shares performed this year? Ekso Bionics' stock was trading at $2.50 on January 1st, 2024. Since then, EKSO shares have decreased by 57.2% and is now trading at $1.07. View the best growth stocks for 2024 here. How were Ekso Bionics' earnings last quarter? Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued its earnings results on Monday, April, 29th. The company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.04. The business earned $3.76 million during the quarter, compared to the consensus estimate of $4.99 million. Ekso Bionics had a negative trailing twelve-month return on equity of 95.36% and a negative net margin of 79.48%. When did Ekso Bionics' stock split? Ekso Bionics shares reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. How do I buy shares of Ekso Bionics? Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Ekso Bionics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ekso Bionics investors own include Organigram (OGI), KushCo (KSHB), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN) and Bionano Genomics (BNGO). This page (NASDAQ:EKSO) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ekso Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
